U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07380711) titled 'Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes' on Jan. 13.
Brief Summary: The OBS19236 is a retrospective and prospective, non-interventional observational study in COPD patients treated with dupilumab as part of routine clinical care. It will follow-up about 350 to 500 participants over 36 months in up to 50 sites in France.
Study Start Date: Feb. 10
Study Type: OBSERVATIONAL
Condition:
Chronic Obstructive Pulmonary Disease COPD
Recruitment Status: RECRUITING
Sponsor: Sanofi
Published by HT Digital Content Services with permission from Health Daily Digest....